The activity of liver enzymes, such as the cytochrome P450 family, is crucial in drug metabolism. In neonates, these enzymes are often underdeveloped, resulting in prolonged drug half-lives and potential toxicity. Over time, enzyme activity increases, but it can be highly variable among different children, making it challenging to predict drug metabolism accurately.
